Detalles de la búsqueda
1.
Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study.
Invest New Drugs
; 32(2): 303-11, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23903897
2.
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors.
Clin Cancer Res
; 28(3): 479-488, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34753777
3.
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study.
Clin Cancer Res
; 26(17): 4531-4541, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586937
4.
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
Clin Cancer Res
; 9(4): 1323-32, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12684400
5.
Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
Arch Immunol Ther Exp (Warsz)
; 50(6): 421-9, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12546068
6.
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seed.
Hum Antibodies
; 13(3): 81-90, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15598988
7.
Blockade of insulin-like growth factor type-1 receptor with cixutumumab (IMC-A12): a novel approach to treatment for multiple cancers.
Curr Drug Targets
; 12(14): 2016-33, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21777192
8.
A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies.
Clin Cancer Res
; 16(6): 1915-23, 2010 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197484
9.
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
J Clin Oncol
; 28(5): 780-7, 2010 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20048182
10.
Effects of 2 different anti-tumor necrosis factor-alpha agents in a primate model of subcutaneous abscess formation.
J Infect Dis
; 185(2): 204-13, 2002 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11807694
Resultados
1 -
10
de 10
1
Próxima >
>>